Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

1. (1)

   in the sixth column, expiration of approval, of row 7, Metsulfuron methyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

2. (2)

   in the sixth column, expiration of approval, of row 9, Triasulfuron, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

3. (3)

   in the sixth column, expiration of approval, of row 10, Esfenvalerate, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

4. (4)

   in the sixth column, expiration of approval, of row 11, Bentazone, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

5. (5)

   in the sixth column, expiration of approval, of row 12, Lambda-cyhalothrin, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

6. (6)

   in the sixth column, expiration of approval, of row 14, Amitrole, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

7. (7)

   in the sixth column, expiration of approval, of row 15, Diquat, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

8. (8)

   in the sixth column, expiration of approval, of row 17, Thiabendazole, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

9. (9)

   in the sixth column, expiration of approval, of row 19, DPX KE 459 (flupyrsulfuron-methyl), the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

10. (10)

    in the sixth column, expiration of approval, of row 20, Acibenzolar-s-methyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

11. (11)

    in the sixth column, expiration of approval, of row 23, Pymetrozine, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

12. (12)

    in the sixth column, expiration of approval, of row 24, Pyraflufen-ethyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

13. (13)

    in the sixth column, expiration of approval, of row 25, Glyphosate, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

14. (14)

    in the sixth column, expiration of approval, of row 26, Thifensulfuron-methyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

15. (15)

    in the sixth column, expiration of approval, of row 27, 2,4-D, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

16. (16)

    in the sixth column, expiration of approval, of row 28, Isoproturon, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

17. (17)

    in the sixth column, expiration of approval, of row 30, Iprovalicarb, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

18. (18)

    in the sixth column, expiration of approval, of row 31, Prosulfuron, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

19. (19)

    in the sixth column, expiration of approval, of row 34, Cyhalofop butyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

20. (20)

    in the sixth column, expiration of approval, of row 35, Famoxadone, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

21. (21)

    in the sixth column, expiration of approval, of row 37, Metalaxyl-M, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

22. (22)

    in the sixth column, expiration of approval, of row 38, Picolinafen, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;

23. (23)

    in the sixth column, expiration of approval, of row 39, Flumioxazine, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’.